Ligong Wang

Title: Ligong Wang: Innovator in Pharmaceutical Compositions

Introduction

Ligong Wang is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance immune responses. His work is characterized by a focus on innovative solutions that address critical health challenges.

Latest Patents

Ligong Wang holds a patent for a pharmaceutical composition comprising CpG oligonucleotides. This invention provides a formulation designed to induce immune responses in subjects. The composition includes an antigen at concentrations ranging from 1 µg/ml to 100 µg/ml, specific CpG oligonucleotides with a defined sequence at concentrations between 25 µg/ml and 500 µg/ml, and an aluminum adjuvant also within the range of 25 µg/ml to 500 µg/ml. This innovative formulation aims to boost the immune response against the antigen in the subject.

Career Highlights

Ligong Wang is associated with Changchun Huapu Biotechnology Co. Ltd., where he applies his expertise in biotechnology and pharmaceuticals. His work at the company reflects his commitment to advancing medical science through innovative research and development.

Collaborations

Ligong Wang collaborates with his coworker, Yan Shao, contributing to the collective efforts in their field. Their partnership exemplifies the importance of teamwork in driving innovation and achieving breakthroughs in pharmaceutical research.

Conclusion

Ligong Wang's contributions to pharmaceutical compositions highlight his role as an innovator in the field. His patent for a composition that enhances immune responses showcases the potential for significant advancements in medical treatments. His work continues to inspire future innovations in biotechnology.